Issue date: July 2009; Review date: December 2010.
"This guidance was developed using the single technology appraisal process."
Rituximab for the first-line treatment of chronic lymphocytic leukaemia by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2009. Publication and catalogue information, links to buy online and reader comments.